首页>
外国专利>
Vaccine against brucellosis in humans - contg. phenol insoluble fraction of defatted Brucella abortus cells
Vaccine against brucellosis in humans - contg. phenol insoluble fraction of defatted Brucella abortus cells
展开▼
机译:预防人类布鲁氏菌病的疫苗-续。脱脂布鲁氏菌流产细胞的苯酚不溶级分
展开▼
页面导航
摘要
著录项
相似文献
摘要
Vaccine against brucellosis comprises, in a suitable vehicle, the phenol-insoluble fraction (A) of Brucella abortus, esp. the strain B19. Pref. (A) is 1.7-2.3, esp. 2, mg (dry basis) per ml solvent and the vaccine is esp. formulated in unit doses of 0.5 ml. The pref. vehicle is a phenol-contg. physiological solvent. The vaccine is made from intact B.abortus cells by (1) removal of lipids; (2) drying; (3) extracting with phenol (esp. phenol satd. with water), at about 60 deg.C; (4) washing the filtered and purified prod. and (5) forming into a homogeneous, sterile suspension. The vaccine is suitable for admin. to humans, e.g. farm workers or veterinary surgeons, and is effective against B. melitensis and B. suis as well as B. abortus. It is nontoxic and induces only very mild hypersensitivity reactions.
展开▼